{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:52:23Z","timestamp":1791064343954,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06844-w","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:39:43Z","timestamp":1791016783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of magnetic resonance imaging-based diagnostic pathway on oncologic outcomes of localised prostate cancer between primary treatment modalities: a Will-Rogers phenomenon?"],"prefix":"10.1007","volume":"44","author":[{"given":"Lingyue","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Jie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Yuanming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Ling","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae Jack","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Sun Sien","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Shyi Peng","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"19","key":"6844_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH et al (2018) MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med 378(19):1767\u20131777","journal-title":"N Engl J Med"},{"issue":"1","key":"6844_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R, Claudon M, Roy C, M\u00e8ge-Lechevallier F et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20(1):100\u2013109","journal-title":"Lancet Oncol"},{"issue":"3","key":"6844_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","volume":"76","author":"V Kasivisvanathan","year":"2019","unstructured":"Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Valerio M, Shanmugabavan Y et al (2019) Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 76(3):284\u2013303","journal-title":"Eur Urol"},{"issue":"25","key":"6844_CR4","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","volume":"312","author":"AR Feinstein","year":"1985","unstructured":"Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312(25):1604\u20131608","journal-title":"N Engl J Med"},{"issue":"6","key":"6844_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/pros.24490","volume":"83","author":"R Diamand","year":"2023","unstructured":"Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G et al (2023) Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy. Prostate 83(6):572\u2013579","journal-title":"Prostate"},{"issue":"2","key":"6844_CR6","doi-asserted-by":"publisher","first-page":"106e9","DOI":"10.1016\/j.urolonc.2022.10.023","volume":"41","author":"A Rakauskas","year":"2023","unstructured":"Rakauskas A, Peters M, Ball D, Kim NHK, Ahmed HU, Winkler M et al (2023) The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon. Urol Oncol 41(2):106e9\u2013e16","journal-title":"Urol Oncol"},{"key":"6844_CR7","doi-asserted-by":"crossref","unstructured":"Roach M 3rd, Hanks G, Thames H Jr., Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. ;65(4):965\u2009\u2013\u200974","DOI":"10.1016\/j.ijrobp.2006.04.029"},{"issue":"2","key":"6844_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"MS Cookson","year":"2007","unstructured":"Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D\u2019Amico AV, Dmochowski RR et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177(2):540\u2013545","journal-title":"J Urol"},{"issue":"5","key":"6844_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.eururo.2024.08.022","volume":"87","author":"V Kasivisvanathan","year":"2025","unstructured":"Kasivisvanathan V, Wai-Shun Chan V, Clement KD, Levis B, Ng A, Asif A et al (2025) VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer. Eur Urol 87(5):512\u2013523","journal-title":"Eur Urol"},{"issue":"4","key":"6844_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N et al (2015) Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390\u2013397","journal-title":"JAMA"},{"issue":"10071","key":"6844_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815\u2013822","journal-title":"Lancet"},{"issue":"4","key":"6844_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/bju.14806","volume":"124","author":"EJ Bass","year":"2019","unstructured":"Bass EJ, Orczyk C, Grey A, Freeman A, Jameson C, Punwani S et al (2019) Targeted biopsy of the prostate: does this result in improvement in detection of high-grade cancer or the occurrence of the Will Rogers phenomenon? BJU Int 124(4):643\u2013648","journal-title":"BJU Int"},{"issue":"1","key":"6844_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijrobp.2017.09.003","volume":"100","author":"PB Romesser","year":"2018","unstructured":"Romesser PB, Pei X, Shi W, Zhang Z, Kollmeier M, McBride SM et al (2018) Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients. Int J Radiat Oncol Biol Phys 100(1):59\u201367","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"6844_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","volume":"23","author":"AU Kishan","year":"2022","unstructured":"Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A et al (2022) Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol 23(2):304\u2013316","journal-title":"Lancet Oncol"},{"issue":"11","key":"6844_CR15","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","volume":"11","author":"M Bolla","year":"2010","unstructured":"Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff R-O, Storme G et al (2010) External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 11(11):1066\u20131073","journal-title":"Lancet Oncol"},{"key":"6844_CR16","doi-asserted-by":"crossref","unstructured":"Courtney O\u2019Toole C, Boakye NF, Hannigan A, Jalali A (2025) Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis. Prostate Cancer and Prostatic Disease. 2026;29(2):247-57.","DOI":"10.1038\/s41391-025-01014-2"},{"issue":"4","key":"6844_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.euo.2023.04.004","volume":"6","author":"IC Weinstein","year":"2023","unstructured":"Weinstein IC, Wu X, Hill A, Brennan D, Omil-Lima D, Basourakos S et al (2023) Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis. Eur Urol Oncol 6(4):355\u2013365","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"6844_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.urolonc.2021.07.027","volume":"40","author":"A Yu","year":"2022","unstructured":"Yu A, Yamany T, Mojtahed A, Hanna N, Nicaise E, Harisinghani M et al (2022) Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. Urol Oncol 40(2):59.","journal-title":"Urol Oncol"},{"issue":"1","key":"6844_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00261-018-1718-6","volume":"44","author":"F Alessandrino","year":"2019","unstructured":"Alessandrino F, Taghipour M, Hassanzadeh E, Ziaei A, Vangel M, Fedorov A et al (2019) Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3\u2009+\u20094 and 4\u2009+\u20093 prostate cancer. Abdom Radiol (NY) 44(1):279\u2013285","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"6844_CR20","doi-asserted-by":"publisher","first-page":"W158","DOI":"10.2214\/AJR.17.18958","volume":"211","author":"N Sadoughi","year":"2018","unstructured":"Sadoughi N, Krishna S, McInnes MDF, Flood TA, Breau RH, Morash C et al (2018) ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy. AJR Am J Roentgenol 211(3):W158\u2013w65","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"6844_CR21","doi-asserted-by":"publisher","first-page":"e2112214","DOI":"10.1001\/jamanetworkopen.2021.12214","volume":"4","author":"K Vaculik","year":"2021","unstructured":"Vaculik K, Luu M, Howard LE, Aronson W, Terris M, Kane C et al (2021) Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort. JAMA Netw Open 4(6):e2112214\u2013e","journal-title":"JAMA Netw Open"},{"issue":"13","key":"6844_CR22","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/cncr.29983","volume":"122","author":"GA Viani","year":"2016","unstructured":"Viani GA, Viana BS, Martin JE, Rossi BT, Zuliani G, Stefano EJ (2016) Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial. Cancer 122(13):2004\u20132011","journal-title":"Cancer"},{"issue":"3","key":"6844_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(25)00656-4","volume":"27","author":"P Nilsson","year":"2026","unstructured":"Nilsson P, Gunnlaugsson A, Beckman L, Widmark A, Fransson P, Hoyer M et al (2026) Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol 27(3):293\u2013301","journal-title":"Lancet Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06844-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06844-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06844-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:02:20Z","timestamp":1791061340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06844-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6844"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06844-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Singhealth Centralised Institutional Review Board (Reference number: CIRB 2009\/763\/D) and was conducted according to the guidelines of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Registry and registration No. of study\/trial","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"723"}}